… High preoperative concentrations of CA 15-3 are, however, … for breast cancer can preclinically
detect recurrent/metastatic disease with lead times of ∼2–9 months, the clinical value of …

… clinical value of somaticTP53 mutations in breast cancer, we assembled clinical and molecular
data on 1,794 women with primary breast cancer … elevated risk of breast cancer ^ specific …

… Herein, we aimed to validate the SCAN-B multicenter infrastructure and provide molecular
analyses of clinical value by developing RNA-seq–derived classifiers for the conventional …

… values of classical (Ki67, ER, PR, HER2) and novel molecular factors (p53, p14 ARF , cyclin
D1, cyclin E, TBX2/3, BRCA1/2, and VEGF) for breast cancer. … breast cancer development. …

… for routine clinical assessment in breast cancer. At present, only estrogen receptor (ER) and
progesterone receptor status are fully accepted as having prognostic and predictive value. …

… To estimate the clinical value of estrogen receptor (ER) β expression in breast cancer we
used an immunohistochemical method to detect the wild-type ERβ in 88 primary breast cancers…

… This study assessed the diagnostic value of US as an adjunct to mammography (MAM) and
a clinical examination (CE) in the diagnosis of breast cancer and the feasibility of selecting …

… all patients with breast cancer. For surveillance of patients with diagnosed breast cancer,
both CA 15–… markers which have been shown to be of prognostic value in breast cancer.legend …

… Recent data confirmed the prognostic value of CTCs in early-stage breast cancer. The
majority of studies used >1 CTCs as a cut off to discriminate prognostic groups because of lower …

… clinical and pathologic staging of the cancer and on the clinical molecular markers available
for breast cancer … Although metaplastic breast carcinoma tumors are usually triple negative …